Paricalcitol
Product Images NDC 10888-5001

6 FDA label images from Banner Pharmacaps · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paricalcitol (NDC 10888-5001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Banner Pharmacaps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Paricalcitol. (Paricalcitol 01)

Chemical Structure For Paricalcitol. (Paricalcitol 01)
Chemical structure of the active ingredient Paricalcitol, showing its molecular configuration with several rings and hydroxyl groups as part of its chemical makeup.*
FDA Label Image

Pattern Of Change In The Mean Values For Serum Ipth During The Stages 3 And 4 Clinical Studies. (Paricalcitol 02)

Pattern Of Change In The Mean Values For Serum Ipth During The Stages 3 And 4 Clinical Studies. (Paricalcitol 02)
A line graph comparing iPTH levels (pg/mL) over 23 weeks between Paricalcitol and Placebo groups. The solid line represents Paricalcitol, showing a decreasing trend in iPTH levels, while the dashed line represents Placebo with relatively stable or slightly increasing iPTH levels. The x-axis is labeled 'Week' and the y-axis 'iPTH pg/mL.' Error bars are shown for data points.*
FDA Label Image

Pattern Of Change In The Mean Values For Serum Ipth During The Stage 5 Clinical Study. (Paricalcitol 03)

Pattern Of Change In The Mean Values For Serum Ipth During The Stage 5 Clinical Study. (Paricalcitol 03)
A line graph comparing iPTH levels (pg/mL) over 12 weeks between Paricalcitol and placebo groups. The x-axis represents weeks (0 to 12), and the y-axis shows iPTH concentration from 100 to 1100 pg/mL. Solid and dashed lines with error bars display trends for Paricalcitol and placebo, respectively.*
FDA Label Image

Principal Display Panel (1 mcg Capsule Bottle Label)

Principal Display Panel (1 mcg Capsule Bottle Label)
Paricalcitol 1 mcg capsules packaging label from Banner Pharmacaps Inc. The label includes the NDC 10888-5001-2, dosage strength of 1 mcg, and a package count of 30 capsules. It states the product is Rx only and provides storage instructions, noting to store at 25°C (77°F) with permissible excursions between 15-30°C (59-86°F). Additional information covers the product's USP designation, alcohol content as a non-aqueous vehicle, and packaging integrity requirements.*
FDA Label Image

Principal Display Panel (2 mcg Capsule Bottle Label)

Principal Display Panel (2 mcg Capsule Bottle Label)
Paricalcitol Capsules 2 mcg label from Banner Pharmacaps Inc. The label includes manufacturer and distributor information, NDC number 10888-5002-2, package size of 30 capsules, and storage instructions. It also states the product is Rx only.*
FDA Label Image

Principal Display Panel (4 mcg Capsule Bottle Label)

Principal Display Panel (4 mcg Capsule Bottle Label)
Paricalcitol Capsules 4 mcg label from Banner Pharmacaps Inc. The label states each capsule contains 4 mcg of Paricalcitol USP with excipients and alcohol, in a 30-capsule bottle. Storage instructions and the NDC 10888-5003-2 are included along with manufacturing details and batch information fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.